Patents Examined by R. Thomas Gallegos
  • Patent number: 4613571
    Abstract: There are disclosed polyprenyl sulfone derivatives of the general formula: ##STR1## wherein n represents an integer of 1-4, R.sub.1 represents an aryl group d R.sub.2 represents a hydroxymethyl or carboxyl group. The polyprenyl sulfone derivatives are prepared by cultivating a microorganism of the genus Nocardia capable of oxidizing a compound of the general formula: ##STR2## wherein n and R.sub.1 have the same meanings as defined above, in a culture medium containing a compound of the above general formula (II), and then collecting the oxidation product from the culture mixture. The polyprenyl sulfone derivatives are useful as intermediates for preparing various useful polyprenyl compounds.
    Type: Grant
    Filed: February 21, 1984
    Date of Patent: September 23, 1986
    Assignees: Esai Co., Ltd., General Director of the Agency of Industrial Science and Technology
    Inventors: Akio Sato, Kenji Nakajima, Yoshimasa Takahara, Shizumasa Kijima, Hideaki Watanabe, Tamio Kawamura, Yasushi Nagai
  • Patent number: 4601983
    Abstract: A genetic sequence coding for the production of a protein having the activity of homoserine dehydrogenase and having two Pst I cleavage sites in its DNA chain and a molecular weight of 2.24 Md, is incorporated into a vehicle capable of replication in Coryneform bacteria and used to produce L-threonine and L-isoleucine by fermentation.
    Type: Grant
    Filed: June 15, 1983
    Date of Patent: July 22, 1986
    Assignee: Ajinomoto Co., Inc.
    Inventors: Shigeru Nakamori, Masaaki Ishida, Hiroshi Takagi, Kiyoshi Miwa, Koichi Ito, Konosuke Sano
  • Patent number: 4595589
    Abstract: The invention relates to a method for preventing fungus diseases in plants grown in, for example, a bed containing peat, by adding to the vegetation or the soil streptomyces griseaviridis stains ATCC 39271, 39272 and 39273. The aqueous suspension preferably contains at least 10.sup.5 spores/ml, and at least 10 ml of the aqueous suspension is spread per one m.sup.2, or the seeds are immersed in the aqueous suspension.
    Type: Grant
    Filed: March 16, 1983
    Date of Patent: June 17, 1986
    Assignee: Kemira Oy
    Inventor: Risto Tahvonen
  • Patent number: 4554251
    Abstract: In vitro culture of the venom gland cells of the ant Pseudomyremex triplarinus is effected by removing venom gland tissue from a larva or pupa of P. triplarinus subjecting the tissue to a protease to separate out the cells therein and culturing the resultant cells in an isotonic saline medium comprising carbohydrate, amino acids guanosine 3',5'-cyclic monophosphate and adenosine 3',5'-cyclic monophosphoric acid, at least part of the medium having been conditioned with Spodoptera frugiperda cells. Such in vitro culture provides a practicable route to volume production of the biologically active materials which are useful for treating the symptoms of rheumatoid arthritis and which the venom gland cells are known to produce.
    Type: Grant
    Filed: November 7, 1983
    Date of Patent: November 19, 1985
    Assignee: The Ohio State University Research Foundation
    Inventor: Walter F. Hink, Jr.